| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-07 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |